Niveles de indolamina 2,3-dioxigenasa en individuos sanos adultos

Bibliographic References

• López AS, Alegre E, Díaz-Lagares A, García-Girón C, Coma MJ, González A. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules IDO and HLA-G in macrophages. Immunol Lett. 2008;117:91-95
• Pertovaara M, Raitala A, Juonala M et al. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis. Clin Exp Immunol. 2007; 148:106-111.
• López AS, García-Girón C, Cavia M, López-Muñoz A, García-González M, Coma MJ, Muñiz P. Inmunotoleracia en tumores gastrointestinales. HLA-G e Indolamina, 2-3, dioxigensasa. Electron J Biomed 2007;3:59-65.
• Wood K, Harwood J, Coppen A. The Effect of Antidepressant Drugs on Plasma Kynurenine in Depressed Patients. Psychopharmacology 1978; 59: 263-266.
• Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997;43:2424-2426.
• Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, Fuchs D. Effective Antiretroviral Therapy Reduces Degradation of Tryptophan in Patients with HIV-1 Infections Clin Immunol 2002; 104: 242-247.
• Cozzi A, Zignego AL, R, Carpendo R, Biagiotti T, Aldinucci A, Monti M, Giannini C, Rosselli M, Laffi G, Moroni F. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients Viral Hepat. 2006; 13:402-408.
• Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B, Kynurenine pathway in major depression: Evidence of impaired neuroprotection Affect Disord. 2007; 98:143-151.
• Hartai Z, Juhasz A, Rimanoczy A, Janaky T, Donko T, Dux L, Penke B, Toth G, Janka Z, Kalman J. Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease. Neurochemistry International 2007; 50: 308-313.
• Buczko P, Tankiewicz-Kwedlo A , Buraczewska A , My?liwiec M, Pawlak D. Accumulation of kynurenine pathway metabolites in salive and plasma of uremic patients. Pharmacological Reports. 2007; 59:199-204.
• Hoshi M, Ito H, Fujigaki H, Takemura M, Takahashi T, Tomita E, Ohyama M, Tanaka R, Saito K, Seishima M. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. Leuk Res. 2009; 33:39-45
• Schefold JC, Zeden JP, Pschowski R, Hammoud B, Fotopoulou C, Hasper D, Fusch G, Von Haehling S, Volk HD, Meisel C, Schütt C, Reinke P. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. Scand J Infect 2010; 42 :164-171.
• Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinat TG. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol. 2009; 9:6
• Zhang X, Show A, He Y, Ding M. Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. J Chromatogr B. 2009; 877: 1678-1682
• Suzuki Y, Suda T, Furuhashi K, Suzuki M, Fujie M, Hahimoto D, Nakamura Y, Inui N, Nakamura H, Chida K. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. Lung Cancer 2010;67: 361-365.
• Lögters TT, Laryea MD, Altrichter J, Sokolowski J, Cinatl J, Reipen J, Linhart W, Windolf J, Scholz M, Wild M. Increased plasma kynurenine values and kynurenine-tryptophan ratios after major trauma are early indicators for the development of sepsis. Shock. 2009;32:29-34
• Alegre E, López AS, González A. Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine. Analitical Biochemistry 2005; 339:188-9
• Pertovaara M, Raitala A, Uusitalo H. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome. Clin Exp Immunol. 2005;142:155-161